GoodRx is growing its relationships with pharmaceutical manufacturers to integrate their savings programs with the GoodRx platform to offer better access to patients for their medications
Philip Morris outlined its Beyond Nicotine strategy at its most recent Investor Day. The company is focusing on selfcare wellness, including botanicals and inhaled therapeutics that are expected to have an addressable market of around $65 billion by 2025.
Saphnelo, while primarily available through the leading specialty drug distributors, is also available through Amber Specialty Pharmacy and US Bioservices
Optum® Frontier Therapies, a specialty pharmacy dedicated to people with rare disease, was founded to optimize every aspect of advanced therapeutics, from the point of prescribing to treatment and beyond
The FDA approved UPTRAVI® (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy
HealthTrust and Steward Health Care announced a long-term extension of the companies’ exclusive agreement for supply chain and GPO support services
SS&C, Anthem, and Humana recently entered into a joint venture, named DomaniRx, LLC, to develop a contemporary, cloud-native platform to support the operation of a full service pharmacy benefits manager
To meet the increasing demand from self-insured employers looking to contract with health care provider networks, Vizient, Inc. announced the launch of its Direct to Employer Solutions for health care systems.